Chernyak V - Search Results

1

MR Imaging Contrast Agents: Role in Imaging of Chronic Liver Diseases.

Chang SD, Cunha GM, Chernyak V. Chang SD, et al. Among authors: chernyak v. Magn Reson Imaging Clin N Am. 2021 Aug;29(3):329-345. doi: 10.1016/j.mric.2021.05.014. Magn Reson Imaging Clin N Am. 2021. PMID: 34243921 Review.

2

Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors.

Chernyak V, Kim J, Rozenblit AM, Mazzoriol F, Ricci Z. Chernyak V, et al. J Magn Reson Imaging. 2011 Aug;34(2):301-9. doi: 10.1002/jmri.22635. Epub 2011 May 23. J Magn Reson Imaging. 2011. PMID: 21608069

3

MR imaging of renal collecting system with gadoxetate disodium: feasibility for MR urography.

Dym RJ, Chernyak V, Rozenblit AM. Dym RJ, et al. Among authors: chernyak v. J Magn Reson Imaging. 2013 Oct;38(4):816-23. doi: 10.1002/jmri.24059. Epub 2013 Feb 13. J Magn Reson Imaging. 2013. PMID: 23408536

4

Solid organ abdominal ischemia, part I: clinical features, etiology, imaging findings, and management.

Ricci ZJ, Oh SK, Stein MW, Kaul B, Flusberg M, Chernyak V, Rozenblit AM, Mazzariol FA. Ricci ZJ, et al. Among authors: chernyak v. Clin Imaging. 2016 Jul-Aug;40(4):720-31. doi: 10.1016/j.clinimag.2016.02.014. Epub 2016 Feb 18. Clin Imaging. 2016. PMID: 27317217 Review.

5

Hollow organ abdominal ischemia, part II: clinical features, etiology, imaging findings and management.

Ricci ZJ, Mazzariol FS, Kaul B, Oh SK, Chernyak V, Flusberg M, Stein MW, Rozenblit AM. Ricci ZJ, et al. Among authors: chernyak v. Clin Imaging. 2016 Jul-Aug;40(4):751-64. doi: 10.1016/j.clinimag.2016.02.016. Epub 2016 Feb 19. Clin Imaging. 2016. PMID: 27317221 Review.

6

Transient arterial phase respiratory motion-related artifact in MR imaging of the liver: an analysis of four different gadolinium-based contrast agents.

Shah MR, Flusberg M, Paroder V, Rozenblit AM, Chernyak V. Shah MR, et al. Among authors: chernyak v. Clin Imaging. 2017 Jan-Feb;41:23-27. doi: 10.1016/j.clinimag.2016.09.004. Epub 2016 Sep 13. Clin Imaging. 2017. PMID: 27736700

7

Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.

Chernyak V, Flusberg M, Law A, Kobi M, Paroder V, Rozenblit AM. Chernyak V, et al. J Comput Assist Tomogr. 2018 Jan/Feb;42(1):155-161. doi: 10.1097/RCT.0000000000000642. J Comput Assist Tomogr. 2018. PMID: 28806321

8

Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI-RADS).

Chernyak V, Fowler KJ, Heiken JP, Sirlin CB. Chernyak V, et al. J Magn Reson Imaging. 2019 May;49(5):1236-1252. doi: 10.1002/jmri.26540. Epub 2019 Jan 4. J Magn Reson Imaging. 2019. PMID: 30609194 Review.

9

User and system pitfalls in liver imaging with LI-RADS.

Elsayes KM, Fowler KJ, Chernyak V, Elmohr MM, Kielar AZ, Hecht E, Bashir MR, Furlan A, Sirlin CB. Elsayes KM, et al. Among authors: chernyak v. J Magn Reson Imaging. 2019 Dec;50(6):1673-1686. doi: 10.1002/jmri.26839. Epub 2019 Jun 18. J Magn Reson Imaging. 2019. PMID: 31215119 Review.

10

Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach.

Zulfiqar M, Sirlin CB, Yoneda N, Ronot M, Hecht EM, Chernyak V, Matsui O, Bastati N, Ba-Ssalamah A, Chatterjee D, Bashir M, Fowler KJ. Zulfiqar M, et al. Among authors: chernyak v. J Magn Reson Imaging. 2020 Jun;51(6):1630-1640. doi: 10.1002/jmri.26902. Epub 2019 Aug 16. J Magn Reson Imaging. 2020. PMID: 31418986 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page